MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knickle, L. C.
Right arrow Articles by Bend, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knickle, L. C.
Right arrow Articles by Bend, J. R.

Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids

LC Knickle and JR Bend

Department of Pharmacology and Toxicology, University of Western Ontario, London, Canada.

Guinea pig lung microsomes converted arachidonic acid (AA) to two classes of cytochrome P450 (P450)-dependent metabolites, 16- through 20- hydroxyeicosatetraenoic acids [(16-20)-OH-AA] and epoxyeicosatrienoic acids (EETs). The rate of formation of (16-20)-OH-AA was approximately 3-fold higher in microsomes from beta-naphthoflavone-induced versus untreated animals. In microsomes from untreated or induced animals EETs, the major class of P450 metabolites in guinea pig lung, were formed in a regioselective manner, with 8,9-, 11,12-, and 14,15- regioisomers accounting for > or = 90% of the total EETs. With isozyme- selective inhibitors and inhibitory antibodies the role of individual pulmonary P450 isozymes in AA metabolism was examined. Metyrapone and SKF-525A (P450 2B selective) inhibited EET formation by > or = 85% with little effect on (16-20)-OH-AA formation. 1-Aminobenzotriazole (1 mM), a mechanism-based inhibitor with low isozyme selectivity, inhibited the formation of both classes of metabolites by > 95%, whereas N-alpha- methylbenzyl-1-aminobenzotriazole (1 microM), a P450 2B-selective mechanism-based inhibitor, abolished EET formation with little effect on (16-20)-OH-AA formation. Antibodies to rabbit P450 2B4 also abolished EET formation without inhibiting the formation of (16-20)-OH- AA, whereas antibodies to rabbit P450 4B1 did not inhibit the formation of either class of metabolites. alpha-Naphthoflavone (P450 1A1 selective in lung) did not inhibit the formation of either class of metabolites. These data demonstrate that the guinea pig orthologue of P450 2B4 is solely responsible for the bioactivation of AA to EETs in guinea pig lung and that a form of P450 other than a 2B, 4B, or 1A isozyme, which is inducible by beta-naphthoflavone, is responsible for (16-20)-OH-AA formation.

Volume 45, Issue 6, pp. 1273-1280, 06/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Yaghi, J. R. Bend, C. D. Webb, D. C. Zeldin, S. Weicker, S. Mehta, and D. G. McCormack
Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1260 - L1267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Yaghi, J. A. Bradbury, D. C. Zeldin, S. Mehta, J. R. Bend, and D. G. McCormack
Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia
Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1099 - L1105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. H. Stephenson, R. S. Sprague, J. L. Losapio, and A. J. Lonigro
Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2153 - H2161.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Yu, R. P. McAndrew, R. Al-Saghir, K. G. Maier, M. Medhora, R. J. Roman, and E. R. Jacobs
Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries
J Appl Physiol, October 1, 2002; 93(4): 1391 - 1399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Fuloria, T. K. Smith, and J. L. Aschner
Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L383 - L389.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin
Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C. Benoit, B. Renaudon, D. Salvail, and E. Rousseau
EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization
Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L965 - L973.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Yaghi, C. D. Webb, J. A. Scott, S. Mehta, J. R. Bend, and D. G. McCormack
Cytochrome P450 Metabolites of Arachidonic Acid but Not Cyclooxygenase-2 Metabolites Contribute to the Pulmonary Vascular Hyporeactivity in Rats with Acute Pseudomonas Pneumonia
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 479 - 488.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. R. Jacobs and D. C. Zeldin
The lung HETEs (and EETs) up
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H1 - H10.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. KISS, H. SCHÜTTE, K. MAYER, H. GRIMM, W. PADBERG, W. SEEGER, and F. GRIMMINGER
Synthesis of Arachidonic Acid-Derived Lipoxygenase and Cytochrome P450 Products in the Intact Human Lung Vasculature
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1917 - 1923.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res., February 1, 2000; 41(2): 163 - 181.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Zhu, M. Bousamra II, D. C. Zeldin, J. R. Falck, M. Townsley, D. R. Harder, R. J. Roman, and E. R. Jacobs
Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries
Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L335 - L343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Salvail, M. Dumoulin, and E. Rousseau
Direct modulation of tracheal Cl--channel activity by 5,6- and 11,12-EET
Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L432 - L441.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. M. S. Pascual, A. McKenzie, J. R. Yankaskas, J. R. Falck, and D. C. Zeldin
Epoxygenase Metabolites of Arachidonic Acid Affect Electrophysiologic Properties of Rat Tracheal Epithelial Cells1
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 772 - 779.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
C. J. Sinal, M. Hirst, C. D. Webb, and J. R. Bend
Enantioselective, Mechanism-Based Inactivation of Guinea Pig Hepatic Cytochrome P450 by N-(alpha -Methylbenzyl)-1-Aminobenzotriazole
Drug Metab. Dispos., July 1, 1998; 26(7): 681 - 688.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. H. Stephenson, R. S. Sprague, and A. J. Lonigro
5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog
Am J Physiol Heart Circ Physiol, July 1, 1998; 275(1): H100 - H109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. S. Keeney, C. Skinner, S. Wei, T. Friedberg, and M. R. Waterman
A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid
J. Biol. Chem., April 10, 1998; 273(15): 9279 - 9284.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Sinal, M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonzalez
Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation
J. Biol. Chem., December 15, 2000; 275(51): 40504 - 40510.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Salvail, M. Cloutier, and E. Rousseau
Functional reconstitution of an eicosanoid-modulated Cl- channel from bovine tracheal smooth muscle
Am J Physiol Cell Physiol, March 1, 2002; 282(3): C567 - C577.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics